HotSheets 2014  
Made possible by charitable contributions from Astellas/Medivation, Takeda, Millennium and Bavarian Nordic.

Click to Zoom

Our monthly newsletter, the HotSheet, highlights the latest in treatment strategies as well as emerging treatments. The HotSheet is distributed free at chapter support group meetings, and is available in PDF on the Us TOO web site. 

HotSheet Personal Subscriptions Now Available

If you are unable to attend chapter meetings to get the latest issue or prefer an original copy, we can deliver the newsletter right to your home or office. Download and print a subscription order form or order online.


January - March | April - June | July - September | October - December


January   | View Newsletter

February    | View Newsletter

March   | View Newsletter

  • New Drug Boosts Prostate Cancer Survival
  • Low Response to Da Vinci Surgery Survey
  • IMRT Feasible for Lymph Node Metastases
  • Prostate Cancer Incidence after Termination of a Population-Based PSA-Screening Program
  • Death Rate from Metastatic Prostate Cancer at Diagnosis Has Not Improved over 20 Years
  • Doc Moyad’s “No Bogus Science” Column - “Magnesium Is Good for Cardiovascular Health” 
  • Index of Articles Published in 2013 HotSheets
  • Doctor Chodak’s Bottom Line
  • Coffee Consumption & Risk of Non-Aggressive, Aggressive & Fatal Prostate Cancer
  • Qigong Improves Prostate Cancer Fatigue
  • Pain Drugs Used During Surgery & Outcome
  • Potential Biological Factor to Explains Racial Disparities in Prostate Cancer
  • Xtandi after Relapse to Docetaxel & Zytiga
  • MRI and CT PET Imaging for Preoperative Pelvic Node Staging in Prostate Cancer
  • Use of Statins and Risk of Death in Patients with Prostate Cancer
  • Doc Moyad’s “No Bogus Science” Column - "Multivitamins – the Piñata of Supplements"
  • Zytiga + Prednisone vs. Prednisone Alone in Chemotherapy-Naïve Men with CRPC
  • Post-RP Pathology in Candidates for AS
  • RT Plus ADT Benefit Confirmed in Men with High-risk Prostate Cancer
  • Long-term Safety of Radium-233 Confirmed in Advanced Castrate Resistant Prostate Cancer
  • Enzalutamide before Chemotherapy Slows Disease Progression in Metastatic Disease
  • Clinical Variables and Response to Abiraterone
  • Media Storm Caused by Deaths in Phase 2 Trial of PSMA Antibody Drug Conjugate
  • New Agent Misses Mark in Advanced Cancer
  • Prostate Health Index May Identify Men on Active Surveillance Requiring Treatment
  • Doc Moyad's "No Bogus Science" Column – "Testosterone, Exercise or Both?"
  • FDA Now Investigating Cardiovascular Risks of Testosterone Supplementation
  • Prolaris Modifies Physician Decision-Making
  • Doctor Chodak's Bottom Line

April   | View Newsletter

May   | View Newsletter

June   | View Newsletter

  • Surgery Better than Watchful Waiting for Younger Prostate Cancer Patients
  • How Selenium and Vitamin E Increase Prostate Cancer Risk
  • Toxicity Limits Potential Use of Less Expensive form of Prostate Cancer Treatment
  • Stress, Lack of Social Support Linked to Prostate Cancer Mortality
  • New Genes for Familial Prostate Cancer
  • Robot-Assisted Prostate Surgery Offers Better Cancer Control (or Does It?)
  • Doc Moyad’s “No Bogus Science” Column – “Limit your sugar intake, says the WHO”
  • Gleason Inflation—1998 to 2011
  • Modified Gleason Grade in PLCO Trial
  • Doctor Chodak’s Bottom Line

July   | View Newsletter

August   | View Newsletter

September   | View Newsletter


October   | View Newsletter

November   | View Newsletter

December   | View Newsletter


Facebook -  Twitter -  LinkedIn - Inspire prostate cancer discussions – 

Contact Us | Privacy Policy | Terms & Conditions | Disclaimer   

Copyright © 2005-2014 Us TOO International, Inc.
Designed and hosted by ACCESS Medical Group, Ltd.